These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15767643)

  • 1. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.
    Verso M; Agnelli G; Bertoglio S; Di Somma FC; Paoletti F; Ageno W; Bazzan M; Parise P; Quintavalla R; Naglieri E; Santoro A; Imberti D; Sorarù M; Mosca S
    J Clin Oncol; 2005 Jun; 23(18):4057-62. PubMed ID: 15767643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer.
    Couban S; Goodyear M; Burnell M; Dolan S; Wasi P; Barnes D; Macleod D; Burton E; Andreou P; Anderson DR
    J Clin Oncol; 2005 Jun; 23(18):4063-9. PubMed ID: 15767639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients.
    Verso M; Agnelli G; Kamphuisen PW; Ageno W; Bazzan M; Lazzaro A; Paoletti F; Paciaroni M; Mosca S; Bertoglio S
    Intern Emerg Med; 2008 Jun; 3(2):117-22. PubMed ID: 18317868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
    Fuji T; Ochi T; Niwa S; Fujita S
    J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
    Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
    N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.
    Bergqvist D; Agnelli G; Cohen AT; Eldor A; Nilsson PE; Le Moigne-Amrani A; Dietrich-Neto F;
    N Engl J Med; 2002 Mar; 346(13):975-80. PubMed ID: 11919306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.
    Agnelli G; Piovella F; Buoncristiani P; Severi P; Pini M; D'Angelo A; Beltrametti C; Damiani M; Andrioli GC; Pugliese R; Iorio A; Brambilla G
    N Engl J Med; 1998 Jul; 339(2):80-5. PubMed ID: 9654538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.
    Colwell CW; Berkowitz SD; Davidson BL; Lotke PA; Ginsberg JS; Lieberman JR; Neubauer J; McElhattan JL; Peters GR; Francis CW
    J Thromb Haemost; 2003 Oct; 1(10):2119-30. PubMed ID: 14521593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.
    Verso M; Agnelli G
    J Clin Oncol; 2003 Oct; 21(19):3665-75. PubMed ID: 14512399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
    Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
    Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.
    Karthaus M; Kretzschmar A; Kröning H; Biakhov M; Irwin D; Marschner N; Slabber C; Fountzilas G; Garin A; Abecasis NG; Baronius W; Steger GG; Südhoff T; Giorgetti C; Reichardt P
    Ann Oncol; 2006 Feb; 17(2):289-96. PubMed ID: 16317012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
    Weitz JI; Cao C; Eriksson BI; Fisher W; Kupfer S; Raskob G; Spaeder J; Turpie AG
    Thromb Haemost; 2010 Dec; 104(6):1150-7. PubMed ID: 20886185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.
    Superficial Thrombophlebitis Treated By Enoxaparin Study Group
    Arch Intern Med; 2003 Jul; 163(14):1657-63. PubMed ID: 12885680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.
    Samama MM; Cohen AT; Darmon JY; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Nguyen H; Olsson CG; Turpie AG; Weisslinger N
    N Engl J Med; 1999 Sep; 341(11):793-800. PubMed ID: 10477777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
    Debourdeau P; Chahmi DK; Zammit C; Farge-Bancel D
    Pathol Biol (Paris); 2008 Jun; 56(4):211-9. PubMed ID: 18395994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trial.
    Navarro-Quilis A; Castellet E; Rocha E; Paz-Jiménez J; Planès A;
    J Thromb Haemost; 2003 Mar; 1(3):425-32. PubMed ID: 12871445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.
    Geerts WH; Jay RM; Code KI; Chen E; Szalai JP; Saibil EA; Hamilton PA
    N Engl J Med; 1996 Sep; 335(10):701-7. PubMed ID: 8703169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.
    Planes A; Vochelle N; Darmon JY; Fagola M; Bellaud M; Compan D; Saliba E; Weisslinger N; Huet Y
    Drugs; 1996; 52 Suppl 7():47-54. PubMed ID: 9042560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local versus central assessment of venographies in a multicenter trial on the prevention of deep vein thrombosis in neurosurgery.
    Rossi R; Agnelli G; Taborelli P; Fioroni C; Zerbi D; Pattacini P; Giugni E; Bagatella P; Vaccarino A
    Thromb Haemost; 1999 Nov; 82(5):1399-402. PubMed ID: 10595626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
    Turpie AG; Gallus AS; Hoek JA;
    N Engl J Med; 2001 Mar; 344(9):619-25. PubMed ID: 11228275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.